Back
Open Access

New evidence from meta-analyses ‒ lessons to learn on the benefits of intravenous ferric carboxymaltose in heart failure.

Session: Iron deficiency as a therapeutic target in heart failure - new evidence, new guidelines
Topic: Chronic Heart Failure
Speaker: Professor J. Butler (Dallas, US)
Sponsored by Charité Friends & Sponsors Trust - Supported by an unrestricted educational grant from Vifor Pharma
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Professor Javed Butler

Baylor Scott and White Health, Dallas (United States of America)
101 presentations
11 followers

4 more presentations in this session

Welcome and introduction.

Speaker: Professor S. Anker (Berlin, DE)

Access
Video
Thumbnail

New evidence from AFFIRM-AHF ‒ implications for clinical practice.

Speaker: Professor P. Ponikowski (Wroclaw, PL)

Access
Video
Thumbnail

Management of iron deficiency in heart failure - what do the guidelines say?

Speaker: Professor A. Stewart Coats (Coventry, GB)

Access
Video
Thumbnail

Panel discussion.

Access
Video
Thumbnail

Access the full session

Iron deficiency as a therapeutic target in heart failure - new evidence, new guidelines

Speakers: Professor J. Butler, Professor S. Anker, Professor P. Ponikowski, Professor A. Stewart Coats
Access
Video
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb